Basit öğe kaydını göster

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

dc.contributor.authorCoates, Alan S.
dc.contributor.authorMastropasqua, Mauro G.
dc.contributor.authorNeven, Patrick
dc.contributor.authorOrosz, Zsolt
dc.contributor.authorOlszewski, Wojciech P.
dc.contributor.authorKnox, Fiona
dc.contributor.authorThuerlimann, Beat
dc.contributor.authorPrice, Karen N.
dc.contributor.authorCastiglione-Gertsch, Monica
dc.contributor.authorGelber, Richard D.
dc.contributor.authorGusterson, Barry A.
dc.contributor.authorGoldhirsch, Aron
dc.contributor.authorViale, Giuseppe
dc.contributor.authorGiobbie-Hurder, Anita
dc.contributor.authorRegan, Meredith M.
dc.contributor.authorDell'Orto, Patrizia
dc.contributor.authorMaiorano, Eugenio
dc.contributor.authorMacGrogan, Gaetan
dc.contributor.authorBraye, Stephen G.
dc.contributor.authorOehlschlegel, Christian
dc.date.accessioned2022-02-18T08:59:35Z
dc.date.available2022-02-18T08:59:35Z
dc.date.issued2008
dc.identifier.citationViale G., Giobbie-Hurder A., Regan M. M. , Coates A. S. , Mastropasqua M. G. , Dell'Orto P., Maiorano E., MacGrogan G., Braye S. G. , Oehlschlegel C., et al., "Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole", JOURNAL OF CLINICAL ONCOLOGY, cilt.26, sa.34, ss.5569-5575, 2008
dc.identifier.issn0732-183X
dc.identifier.otherav_0f3f3168-a191-413b-8a3c-2b877cd7650a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/176278
dc.identifier.urihttps://doi.org/10.1200/jco.2008.17.0829
dc.description.abstractPurpose To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOncology
dc.subjectHealth Sciences
dc.titlePrognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.departmentUniversity Of Milan , ,
dc.identifier.volume26
dc.identifier.issue34
dc.identifier.startpage5569
dc.identifier.endpage5575
dc.contributor.firstauthorID3376288


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster